1.
Lancet Oncol
; 25(5): e175, 2024 May.
Article
En
| MEDLINE
| ID: mdl-38697158
Antiemetics , Antineoplastic Agents , Benzodiazepines , Nausea , Olanzapine , Vomiting , Humans , Antiemetics/therapeutic use , Antineoplastic Agents/adverse effects , Benzodiazepines/adverse effects , Benzodiazepines/therapeutic use , Nausea/chemically induced , Nausea/drug therapy , Olanzapine/adverse effects , Olanzapine/therapeutic use , Treatment Outcome , Vomiting/chemically induced , Vomiting/prevention & control